ABBV vs STE · P/E 81, rev $61.16B vs P/E 25, rev $5.46B
AbbVie Inc (ABBV) versus STERIS plc (STE) — a side-by-side from cached financials, not a winner call.
AbbVie Inc (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.
STERIS plc (STE) is a medical devices company listed on NYSE.
Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 305.0% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B and trailing P/E 80.5.
Latest reported STE revenue for 2025-03-31 was $5.46B. Net income was $616.1M. Revenue was up 284.6% from 2024-03-31 to 2025-03-31. STE currently screens at market cap $19.43B and trailing P/E 25.1.
ABBV currently screens at market cap $334.34B and trailing P/E 80.5. STE currently screens at market cap $19.43B and trailing P/E 25.1.
Not investment advice. Open the ABBV and STE stock pages for the full models.
Not investment advice.